Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - disodium pamidronate -

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pamidronate disodium - powder for solution - 60mg - pamidronate disodium 60mg - bone resorption inhibitors

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pamidronate disodium - powder for solution - 90mg - pamidronate disodium 90mg - bone resorption inhibitors

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pamidronate disodium - powder for solution - 30mg - pamidronate disodium 30mg - bone resorption inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 30 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 90 anhyd milligrams

Philippines - English - FDA (Food And Drug Administration)

new smart formulae trading corporation - angelicae sinesis radix , angelicae dahuricae radix , armeniacae amarum semen , scrophulariae radix , gleditsia sinesis lamarck , aconiti kusnezoffi radix , allium fistulosum herba , olibanum , myrrha , yellow beeswax, menthol , methyl salicylate , zinc oxide , resin - medicated plaster - formulation each plaster contains: angelicae sinesis radix-10 mg angelicae dahuricae radix-10 mg armeniacae amarum semen-10 mg scrophulariae radix-10 mg gleditsiae sinesis lamarck-10 mg aconti kusnezoffii radix-10 mg allium fistulosum herba-31 mg olibanum-17 mg myrrha-17 mg yellow beeswax-31 mg menthol-40 mg methyl salicylate-10 mg zinc oxide-20 mg resin-774 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 30 anhyd milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 90 anhyd milligrams

United States - English - NLM (National Library of Medicine)

farmea - methsuximide (unii: 0g76k8x6c0) (methsuximide - unii:0g76k8x6c0) - celontin is indicated for the control of absence (petit mal) seizures that are refractory to other drugs. methsuximide should not be used in patients with a history of hypersensitivity to succinimides.